These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8155397)

  • 1. Phase II study of vinblastine and doxorubicin in advanced renal cell carcinoma.
    Jekunen A; Stengård J; Pyrhönen S
    Eur J Cancer; 1994; 30A(2):245. PubMed ID: 8155397
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
    Schwartsmann G; Medina de Cunha F; Silveira LA; Salgado G; Thereza MS; Vinholes J; Preger P; Segal F
    Ann Oncol; 1991 Jun; 2(6):443. PubMed ID: 1768632
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined interferon and vinblastine treatment in advanced renal cell cancer.
    Kellokumpu-Lehtinen P; Jantunen I; Flander M; Johansson R; Nordman E
    Acta Oncol; 1995; 34(7):975-7. PubMed ID: 7492395
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
    Sommer HH; Fosså SD; Lien HH
    Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB).
    Sorio R; Galligioni E; Crivellari D; Talamini R; Monfardini S
    Ann Oncol; 1995 Mar; 6(3):306-7. PubMed ID: 7612500
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon plus vinblastine in renal carcinoma patients who had failed on interferon alone.
    Merimsky O; Chaitchik S
    Eur J Cancer; 1990; 26(8):921. PubMed ID: 2145941
    [No Abstract]   [Full Text] [Related]  

  • 7. Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma.
    Tai CJ
    Acta Oncol; 2009; 48(6):931-2. PubMed ID: 19925379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
    Masuda F; Nakada J; Kondo I; Furuta N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2143-6. PubMed ID: 1888185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.
    Masuda F; Nakada J; Kondo I; Furuta N
    Cancer Chemother Pharmacol; 1992; 30(6):477-9. PubMed ID: 1394804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
    Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
    Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].
    Kakehi Y; Hashimura T; Yoshida O; Segawa T; Kanematsu A
    Hinyokika Kiyo; 1993 Dec; 39(12):1227-32. PubMed ID: 8285174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of renal cell carcinoma. II. Adriamycin and carboquone combined chemotherapy].
    Osawa T
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1805-13. PubMed ID: 3573463
    [No Abstract]   [Full Text] [Related]  

  • 13. [A combined chemo-endocrine therapy of advanced renal cell carcinoma].
    Wada T; Yasutomi M; Abe T; Wada A
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2294-8. PubMed ID: 3128617
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II trial of vinblastine plus dipyridamole in advanced renal cell carcinoma. A Hoosier Oncology Group Study.
    Murphy BR; Rynard SM; Pennington KL; Grosh W; Loehrer PJ
    Am J Clin Oncol; 1994 Feb; 17(1):10-3. PubMed ID: 8311000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
    Bergerat JP; Herbrecht R; Dufour P; Jacqmin D; Bollack C; Prevot G; Bailly G; de Garis S; Juraschek F; Oberling F
    Cancer; 1988 Dec; 62(11):2320-4. PubMed ID: 3141036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
    Swanson DA
    Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
    Kellokumpu-Lehtinen P; Nordman E
    J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.
    Liu JH; Yang MH; Fan FS; Yen CC; Wang WS; Chang YH; Chen KK; Chen PM
    Urology; 2001 Apr; 57(4):650-4. PubMed ID: 11306370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].
    Kakehi Y; Yoshida O; Segawa T; Kanematsu A; Hiura M; Shichiri Y; Arai Y
    Hinyokika Kiyo; 1994 Oct; 40(10):925-9. PubMed ID: 7992710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancer.
    Lupera H; Theodore C; Ghosn M; Court BH; Wibault P; Droz JP
    Urology; 1989 Nov; 34(5):281-3. PubMed ID: 2815451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.